IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy.
Nat Cancer
; 2(10): 1055-1070, 2021 10.
Article
in En
| MEDLINE
| ID: mdl-35121883
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
ErbB Receptors
/
Neoplasms
Type of study:
Prognostic_studies
Language:
En
Journal:
Nat Cancer
Year:
2021
Type:
Article
Affiliation country:
Israel